Home / Business and Economy / Vaxxinova Vaccine Wins Prestigious Animal Health Award
Vaxxinova Vaccine Wins Prestigious Animal Health Award
28 Feb
Summary
- Vaxxinova received the 2025 Animal Health Award for Best New Food Animal Product.
- Their Vaxxon SHS vaccine protects poultry against swollen head syndrome.
- The US granted first-ever approval for a live food animal vaccine importation in 2025.
Vaxxinova has been recognized with the 2025 Animal Health Award for Best New Food Animal Product, a testament to its innovative Vaxxon SHS vaccine. This lyophilized live attenuated avian metapneumovirus vaccine is designed to protect poultry against swollen head syndrome.
With over two decades of successful field performance globally, Vaxxon SHS marked a significant regulatory achievement in 2025. The United States granted Vaxxinova its first-ever approval for the importation of a live vaccine for food-producing animals. This authorization, under a Veterinary Biological Product Permit, offered emergency access to a vital solution for turkey and poultry producers impacted by avian metapneumovirus.
The award specifically lauded Vaxxinova's market-driven innovation, regulatory success, strong customer impact, and the vaccine's unique, proven performance. The successful introduction of Vaxxon SHS into the U.S. market was a collaborative effort involving producers, industry associations, and regulatory authorities. Producers have reported substantial benefits from vaccination programs utilizing Vaxxon SHS, with Vaxxinova also offering an inactivated autogenous aMPV vaccine for a comprehensive priming and boost strategy.
